Caricamento...
Surgical resection of advanced gastric cancer following trastuzumab/oxaliplatin/capecitabine combination therapy
Late-stage gastric adenocarcinoma patients have a poor prognosis because of high recurrence rates. To improve long-term outcomes, perioperative chemotherapies are combined with surgery. Human epidermal growth factor receptor 2 (HER2) overexpression had been noted in gastric cancer; therefore, trastu...
Salvato in:
| Autori principali: | , , , , , |
|---|---|
| Natura: | Artigo |
| Lingua: | Inglês |
| Pubblicazione: |
Baishideng Publishing Group Inc
2014
|
| Soggetti: | |
| Accesso online: | https://ncbi.nlm.nih.gov/pmc/articles/PMC4161824/ https://ncbi.nlm.nih.gov/pubmed/25232273 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.3748/wjg.v20.i34.12355 |
| Tags: |
Aggiungi Tag
Nessun Tag, puoi essere il primo ad aggiungerne! !
|